HomeAI · summaries
Storia in 4 fonti
FDA approves Xocova for COVID-19 prevention after exposure
The FDA on Monday approved the first medication for COVID-19 prevention that people can take after they have been exposed to someone with the disease, according to the drug’s manufacturer, Shionogi.Xocova (ensitrelvir) was approved as COVID-19 post-exposure prophylaxis for patients aged 12 years or older, the drug maker announced.
Confronto fonti
4 prospettive sulla stessa storiaTimeline cronologica
- ·
healio.com
FDA approves Xocova for COVID-19 prevention after exposure
The FDA on Monday approved the first medication for COVID-19 prevention that people can take after they have been exposed to someone with the disease, according to the drug’s…
- ·
medpagetoday.com
FDA Approves Oral Antiviral to Prevent COVID-19 After Exposure
Ensitrelvir cut household contacts' risk of developing COVID by more than half
- ·
fiercepharma.com
Shionogi's COVID antiviral Xocova passes muster with FDA as post-exposure preventative
After a prior misfire in demonstrating its protease inhibitor ensitrelvir’s potential as a COVID-19 treatment for U.S. | After a prior misfire in demonstrating its protease…
- ·
endpoints.news
Shionogi wins US approval for first pill to prevent Covid following exposure
Shionogi won FDA approval for Xocova, an oral antiviral to prevent Covid-19 after exposure in people 12 and older who've been in contact with an infected individual.